Dentsply Posts Loss, Misses Third-Quarter Forecasts
The dental products maker reported a third-quarter net loss and revenue below analyst expectations.
Updated on Nov. 5, 2026 in Public Companies

Dentsply International reported a $2 million third-quarter loss, or 1 cent per share, as adjusted earnings of 29 cents per share and revenue of $836 million fell short of Wall Street forecasts. The Charlotte, North Carolina company's results missed analyst estimates of 30 cents per share and $856 million.
Why it matters
The shortfall against consensus expectations signals pressure on the company's near-term performance in a key quarter. Investors will weigh the results against Dentsply's updated full-year outlook.
Dentsply's third-quarter net loss of $2 million and adjusted EPS of 29 cents trailed analyst averages of 30 cents, while revenue of $836 million came in below the $856 million consensus. The source material does not explain the specific factors behind these gaps.
The players
Dentsply International
A Charlotte, North Carolina-based dental products manufacturer that supplies dental equipment, consumables, and prosthetics to dental professionals worldwide.
The details
Dentsply International, headquartered in Charlotte, North Carolina, reported third-quarter results showing a loss of 1 cent per share on a GAAP basis and adjusted earnings of 29 cents per share. The company also reaffirmed its outlook, expecting full-year earnings of $1.20 to $1.30 per share and revenue of $3.5 billion.
Timeline
- November 5, 2026: Dentsply reported its third-quarter earnings results.
Market Landscape
Dentsply's quarter is judged against the Zacks Investment Research consensus, which sets the benchmark for whether results meet or miss expectations. The miss against that consensus on both earnings and revenue places the company below the forecasts that shape investor sentiment in its sector.
Shareholders and prospective investors can use Dentsply's guidance of $1.20 to $1.30 per share to gauge expected full-year profitability. The quarterly miss may influence how the stock is valued in the near term.
The takeaway
A single quarter's miss against consensus is worth weighing against the company's full-year guidance rather than in isolation. Readers tracking the stock should compare the reported results with the updated outlook before drawing conclusions.
Further reading
Track more corporate earnings coverage in Public Companies.
Source note: This article includes information reported by WTOP.










